Search filters

Authors whose works are in public domain in at least one jurisdiction

List of works by Joseph E Blaney

A Single Dose of the DENV-1 Candidate Vaccine rDEN1Δ30 Is Strongly Immunogenic and Induces Resistance to a Second Dose in a Randomized Trial ⬇️

scientific article published on August 2, 2011

A replication-deficient rabies virus vaccine expressing Ebola virus glycoprotein is highly attenuated for neurovirulence

scientific article

A trade-off in replication in mosquito versus mammalian systems conferred by a point mutation in the NS4B protein of dengue virus type 4.

scientific article published on July 2003

Antibody quality and protection from lethal Ebola virus challenge in nonhuman primates immunized with rabies virus based bivalent vaccine

scientific article (publication date: 2013)

Antiviral activity of the EB peptide against zoonotic poxviruses ⬇️

scientific article published on January 6, 2012

Arguments for live flavivirus vaccines

scientific article published in August 2004

Characterizing monkeypox virus specific CD8+ T cell epitopes in rhesus macaques

scientific article published on 28 September 2013

Comparative Analysis of Monkeypox Virus Infection of Cynomolgus Macaques by the Intravenous or Intrabronchial Inoculation Route ⬇️

scientific article published on December 8, 2010

Controlled viral glycoprotein expression as a safety feature in a bivalent rabies-ebola vaccine

scientific article

Cowpox virus infection of cynomolgus macaques as a model of hemorrhagic smallpox ⬇️

scientific article published on August 15, 2011

Dengue virus type 3 vaccine candidates generated by introduction of deletions in the 3′ untranslated region (3′-UTR) or by exchange of the DENV-3 3′-UTR with that of DENV-4

scientific article (publication date: 6 February 2008)

Development of a live attenuated dengue virus vaccine using reverse genetics

scientific article

Ebola virus modulates transforming growth factor β signaling and cellular markers of mesenchyme-like transition in hepatocytes

scientific article

Evaluation of Monkeypox Disease Progression by Molecular Imaging ⬇️

scientific article published on October 19, 2011

Evaluation of St. Louis encephalitis virus/dengue virus type 4 antigenic chimeric viruses in mice and rhesus monkeys

scientific article (publication date: 5 August 2008)

Exposure of rhesus monkeys to cowpox virus Brighton Red by large-particle aerosol droplets results in an upper respiratory tract disease.

scientific article published on 9 May 2016

Further characterization of the immune response in mice to inactivated and live rabies vaccines expressing Ebola virus glycoprotein

scientific article

Genetic basis of attenuation of dengue virus type 4 small plaque mutants with restricted replication in suckling mice and in SCID mice transplanted with human liver cells

scientific article published on August 2002

Genetically modified, live attenuated dengue virus type 3 vaccine candidates

scientific article

Inactivated or live-attenuated bivalent vaccines that confer protection against rabies and Ebola viruses

scientific article

Inhibition of cowpox virus and monkeypox virus infection by mitoxantrone ⬇️

scientific article published on December 11, 2011

Intrabronchial inoculation of cynomolgus macaques with cowpox virus ⬇️

scientific article published on September 21, 2011

Introduction of mutations into the non-structural genes or 3' untranslated region of an attenuated dengue virus type 4 vaccine candidate further decreases replication in rhesus monkeys while retaining protective immunity

scientific article published on September 2004

Matched longitudinal analysis of biomarkers associated with survival

scientific article

Monkeypox virus infection of rhesus macaques induces massive expansion of natural killer cells but suppresses natural killer cell functions

scientific article

Mutations which enhance the replication of dengue virus type 4 and an antigenic chimeric dengue virus type 2/4 vaccine candidate in Vero cells ⬇️

scientific article published on October 1, 2003

Paired Charge-to-Alanine Mutagenesis of Dengue Virus Type 4 NS5 Generates Mutants with Temperature-Sensitive, Host Range, and Mouse Attenuation Phenotypes ⬇️

scientific article published on January 1, 2002

Phase 1 Trial of the Dengue Virus Type 4 Vaccine Candidate rDEN4 30-4995 in Healthy Adult Volunteers

scientific article (publication date: November 2009)

Phase I clinical evaluation of rDEN4Delta30-200,201: a live attenuated dengue 4 vaccine candidate designed for decreased hepatotoxicity

scientific article

Poxvirus Antigen Staining of Immune Cells as a Biomarker to Predict Disease Outcome in Monkeypox and Cowpox Virus Infection in Non-Human Primates ⬇️

scientific article published on April 5, 2013

Preclinical Development of Inactivated Rabies Virus-Based Polyvalent Vaccine Against Rabies and Filoviruses

scientific article

Recombinant, live-attenuated tetravalent dengue virus vaccine formulations induce a balanced, broad, and protective neutralizing antibody response against each of the four serotypes in rhesus monkeys

scientific article

Simian hemorrhagic fever virus infection of rhesus macaques as a model of viral hemorrhagic fever: clinical characterization and risk factors for severe disease ⬇️

scientific article published on October 19, 2011

Small particle aerosol inoculation of cowpox Brighton Red in rhesus monkeys results in a severe respiratory disease

scientific article published on 14 March 2015

Substitution of the structural genes of dengue virus type 4 with those of type 2 results in chimeric vaccine candidates which are attenuated for mosquitoes, mice, and rhesus monkeys ⬇️

scientific article published on October 1, 2003

Systems Kinomics Demonstrates Congo Basin Monkeypox Virus Infection Selectively Modulates Host Cell Signaling Responses as Compared to West African Monkeypox Virus ⬇️

scientific article published on December 28, 2011

Targeted mutagenesis as a rational approach to dengue virus vaccine development

scientific article

The effect of volume of interest definition on quantification of lymph node immune response to a monkeypox virus infection assessed by (18)F-FDG-PET.

scientific article

The live attenuated dengue serotype 1 vaccine rDEN1Delta30 is safe and highly immunogenic in healthy adult volunteers.

scientific article published on 24 July 2006

Vaccine candidates derived from a novel infectious cDNA clone of an American genotype dengue virus type 2

scientific article

Vaccine candidates for dengue virus type 1 (DEN1) generated by replacement of the structural genes of rDEN4 and rDEN4Delta30 with those of DEN1

scientific article (publication date: 28 February 2007)

[18F]-Fluorodeoxyglucose Uptake in Lymphoid Tissue Serves as a Predictor of Disease Outcome in the Nonhuman Primate Model of Monkeypox Virus Infection

scientific article

rDEN2/4Delta30(ME), a live attenuated chimeric dengue serotype 2 vaccine is safe and highly immunogenic in healthy dengue-naïve adults.

scientific article published on 5 November 2006

rDEN4delta30, a live attenuated dengue virus type 4 vaccine candidate, is safe, immunogenic, and highly infectious in healthy adult volunteers

scientific article published on 27 January 2005

Paulina is supported by:

About Paulina

Help